Optimizing care for head and neck cancer surgery patients
Part of Cancer, Mouth & dental clinical trials.
This trial uses a computer system to send reminders and tracking alerts to doctors and patients, aiming to improve care and outcomes after surgery for head and neck cancer. It may help you stay on track with your treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with squamous cell carcinoma of the mouth or voice box (larynx).
- Your diagnosis was between July 2024 and September 2026.
- You are scheduled to have surgery as the main treatment for your cancer.
- You are being treated at the Centre Hospitalier de l'Université de Montréal (CHUM).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a navigation program (help from a care coordinator) versus usual care to help people start the recommended “next-step” treatments (like radiation, sometimes with chemo) on time after surgery. It’s for certain stages of squamous cell cancer in the head and neck area where late treatment could matter.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This trial uses a smartphone app to track your symptoms during radiation treatment for head and neck cancer. It aims to help your care team catch problems early and improve your quality of life.
This trial tests whether video call speech therapy consultations can work well for people with head and neck (ORL) cancer who need speech/voice support during treatment. It may help you get care closer to home while still being guided by speech therapists.
This trial tests giving a combination of two drugs (an immunotherapy drug called a PD-1 inhibitor and a targeted therapy called cetuximab) before surgery to shrink head and neck cancers. The goal is to see if this approach lowers the chance of the cancer coming back after surgery.
This study enrolls adults with a first-time head and neck cancer diagnosis and collects health and treatment information to better understand the disease. It may help clinicians improve care by learning which treatments and patient features matter most.
Hear when a new Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.